Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9416185 Humanized antibodies against TL1A

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Viktor Roschke0

Bridget A. Cooksey0

Craig Rosen0

Palanisamy Kanakaraj0

Rodger Smith0

Date of Patent

August 16, 2016

0

Patent Application Number

142446030

Date Filed

April 3, 2014

0

Patent Citations Received

US Patent 12084722 Methods of determining responsiveness to anti-TNFα therapy in inflammatory bowel disease

0

US Patent 11999789 Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereof

0

Patent Primary Examiner

Laura B Goddard

0

Patent abstract

Disclosed are humanized antibodies that bind specifically to TNF superfamily member 15 (TNFSF15), also known as TL1A. Methods of making and using the anti-TL1A antibodies are also described. The humanized antibodies may be antagonists and may used to treat or diagnose conditions associated with TL1A function.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9416185 Humanized antibodies against TL1A

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool